Replay available

ALS Limited (ALQ) Q4 2026 Earnings Call

ALS Limited (ASX: ALQ) Q4 2026 earnings conference call, held 2026-05-18. Replay captured from the company's public earnings webcast.

Sun, May 17, 2026 at 8:00 PMendedReplay
ALS Limited (ALQ) Q4 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Mr. Mel Khan Dean

CEO and Managing Director at ALS Limited

Stuart Hadron

Chief Financial Officer at ALS Limited

John Patel

at Macquarie

Rohan Sundram

at MST Pharmaceuticals

Nicholas Robinson

at Morgan

Jacob Kacanis

at Jardan Australia

Nathan Riley

at UBS

Cameron Deatham

at Bank of America

Nicolas Dech

at RBC

Niraj Shah

at Goldman Sachs

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to ALS Limited FY twenty six results briefing. At this time, all participants are in a listen only mode. After the speaker's presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to turn the call over to your first speaker today, Mr. Mel Khan Dean, CEO and Managing Director. Thank you. Please go ahead. Thanks, Desmond, and good morning, and thank you, everyone, for joining us today. It's been a very strong year for Erez, and we've delivered record results, reflecting our ability to achieve strong growth while staying disciplined on margin performance, cash generation and capital allocation. As always, I'm joined by Stuart Hadron, our Chief Financial Officer. We'll speak for around thirty minutes, and then we will open for questions. Four years ago, we set ourselves ambitious fiscal year 'twenty seven targets. I'm pleased to report that we have achieved these targets twelve months early while refining our strategy and focus for the future. What's most pleasing is that we achieved the fiscal year 'twenty seven plan primarily through strong organic growth. Fiscal year 'twenty six revenue was $3,320,000,000 up 10.7%, with strong organic growth of 8.4% at the top end of our guided range, reflecting the breadth of our global operations. Underlying EBIT of $599,000,000 up 19.3%, with EBIT margin accelerating by 129 basis points to 18%. But excluding recent acquisitions, the legacy underlying EBIT margin was 19.8%. Underlying NPAT was up by 25.8% to $381,200,000 a record result for this company. These results for ALS reflects the work of more than 23,000 people across our global network. So I want to acknowledge that upfront, because this was a ...

More from Als Ltd.